TRICARE Pharmacy

Army National Guard: State Active Duty

Benefit Fact Sheet

Share on Facebook Share on X Share on LinkedIn
Summary

TRICARE provides a pharmacy benefit to all eligible soldiers, including beneficiaries entitled to Medicare Part A and B based on their age. Eligible beneficiaries may fill prescription medications at military treatment facility (MTF) pharmacies; through the TRICARE Express Scripts, Inc. (Express Scripts); at TRICARE retail network pharmacies; and at non-network retail pharmacies. Prescriptions filled through the MTF, TRICARE Pharmacy Home Delivery, and retail network pharmacies are checked for accuracy and are checked against your TRICARE prescription history for potential drug interactions. To have a prescription filled; beneficiaries need a written prescription and a valid Uniformed Services identification card.

DFAS will provide IRS Form 1095-C to all U.S. military members, and IRS Form 1095-B to all Retirees, Annuitants, former spouses and all other individuals having TRICARE coverage during all or any portion of tax year 2023. An IRS Form 1095 documents you (and your family members, if applicable) have the minimum essential coverage. These forms will document the information that DFAS will provide to the IRS on yourself and your authorized family members. According to the IRS, these forms are not required to prepare or file income tax returns but will be available via myPay no later than 31 January 2024.

Eligibility

National Guard Soldiers on state active duty status and their family members are not eligible for TRICARE Pharmacy Benefits unless enrolled in TRICARE Reserve Select (TRS).

Additional Information

For more information, please visit the TRICARE Pharmacy Program webpage maintained by the TRICARE Management Activity:
https://tricare.mil/pharmacy.aspx

TRICARE Pharmacy Program Handbook:
https://tricare.mil/-/media/Files/TRICARE/Publications/Handbooks/TRICARE_Pharmacy_Program_Handbook_June_2023_FINAL_063023_508.pdf

TRICARE DEERS Information:
https://tricare.mil/DEERS

Document Review Date: 16 January 2024